These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 990518)

  • 21. [Conditions of action of cytotoxic antibodies (fixing complement) in the rejection of tumoral homografts].
    Callejas F; Kinsky RG; Voisin GA
    Ann Inst Pasteur (Paris); 1972 Jul; 123(1):125-6. PubMed ID: 4640717
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal transplantation in rabbits. VII. IgG deposits in allografts from recipients with lymphocytotoxic antibodies induced by multiple skin-grafts.
    Lund B; Hansen ES
    Acta Pathol Microbiol Scand A; 1972; 80(3):391-402. PubMed ID: 4558136
    [No Abstract]   [Full Text] [Related]  

  • 23. Adoptive transfer of immunity to intraocular tumors in mice.
    Niederkorn JY; Streilein JW
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):336-42. PubMed ID: 6421767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-Binding Allogeneic IgG Stimulates Antitumor T-Cell Responses.
    Cancer Discov; 2015 Jul; 5(7):OF19. PubMed ID: 25977223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cells of the fetomaternal interface: their role in the maintenance of viviparous pregnancy.
    Lala PK; Kearns M; Colavincenzo V
    Am J Anat; 1984 Jul; 170(3):501-17. PubMed ID: 6475813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte-antibody interactions in immunological enhancement.
    Takasugi M; Hildemann WH
    Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
    [No Abstract]   [Full Text] [Related]  

  • 29. Transfer of antibodies directed to paternal major histocompatibility class I antigens from pregnant mice to the developing fetus.
    Adeniyi-Jones SC; Ozato K
    J Immunol; 1987 Mar; 138(5):1408-15. PubMed ID: 3805722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tissue incompatibility on a mother-fetus model].
    Viazov OE; Verbitskiĭ MSh
    Usp Sovrem Biol; 1968; 66(3):424-38. PubMed ID: 4916818
    [No Abstract]   [Full Text] [Related]  

  • 31. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
    Niederkorn J; Streilein JW; Shadduck JA
    Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice.
    Rashid A; Auchincloss H; Sharon J
    J Immunol; 1992 Mar; 148(5):1382-8. PubMed ID: 1538121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-induced skin heterogenization. I. Reciprocal relationship between tumors and skin grafts.
    Mkheidze DM; Liozner AL; Svet-Moldavsky GJ
    J Natl Cancer Inst; 1970 Sep; 45(3):465-73. PubMed ID: 4331640
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.
    Nakamura K; Murase N; Becich MJ; Furuya T; Todo S; Fung JJ; Starzl TE; Demetris AJ
    Am J Pathol; 1993 May; 142(5):1383-91. PubMed ID: 8494042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological mechanisms of survival and "rejection" of the fetal allograft.
    Beer AE; Quebbeman JF
    Mead Johnson Symp Perinat Dev Med; 1986; (24):20-6. PubMed ID: 2943949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Why does a tumor grow?].
    Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A
    Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837
    [No Abstract]   [Full Text] [Related]  

  • 37. [Establishment of double grafted tumor model in mice and role of "tumor necrosis factor" (TNF)].
    Kita M; Sakata K; Imanishi J
    C R Seances Soc Biol Fil; 1991; 185(5):370-4. PubMed ID: 1806196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth of tumors in allogeneic hosts after organ culture explantation. II. Tumor-host interactions.
    Jacobs BB
    J Natl Cancer Inst; 1969 Apr; 42(4):537-43. PubMed ID: 4887236
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation.
    Rouas-Freiss N; Naji A; Durrbach A; Carosella ED
    Transplantation; 2007 Jul; 84(1 Suppl):S21-5. PubMed ID: 17632407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of the athymic nude mouse for growth of human tumors: some current problems.
    Shin S
    Birth Defects Orig Artic Ser; 1980; 16(2):145-53. PubMed ID: 7213962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.